Amussen Hunsaker Associates LLC Amgen Inc Transaction History

Amussen Hunsaker Associates LLC

  • $645 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 19, 2019
SELL
$178.4 - $208.25 $76,712 - $89,547
-430 Closed
0 $0
Q3 2018

Nov 16, 2018
BUY
$185.29 - $208.89 $74,116 - $83,556
400 Added 1333.33%
430 $82,000
Q2 2018

Aug 16, 2018
BUY
$166.05 - $186.51 $4,981 - $5,595
30 New
30 $6,000

Others Institutions Holding AMGN

# of Institutions
3,084
Shares Held
417M
Call Options Held
7.18M
Put Options Held
6.28M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Amussen Hunsaker Associates LLC Portfolio

Follow Amussen Hunsaker Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amussen Hunsaker Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Amussen Hunsaker Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email